DSM-FIRMENICH AG

DSM‑Firmenich AG’s unique blend of nutrition, flavor, and fragrance offers growth despite market‑low stock, yet personalized nutrition and supply‑chain risks loom—watch ESG, AI and emerging‑beauty markets for value.

Explore DSM‑Firmenich AG’s strategy for thriving in specialty ingredients: insights on margins, regulations, and growth in yeast‑based, alcoholic, protein‑masking, and mouthfeel markets.

Discover how DSM‑Firmenich’s focus on high‑purity dietary fibres and organic trace minerals drives innovation, sustainability, and growth in both food and animal feed markets.

DSM‑Firmenich’s 2025 divestiture of its Animal Nutrition unit frees €300 million for R&D and growth in human nutrition, boosting EPS and ESG appeal.

DSM‑Firmenich continues its share repurchase plan, boosting EPS and free‑cash flow while capitalising on the ingredients market’s shift toward natural, functional products.

DSM‑Firmenich AG extends its share‑repurchase program, boosting EPS, ROE and shareholder confidence while supporting a leaner equity base for long‑term value.

DSM-Firmenich AG has made significant strides in achieving its sustainability and financial goals, including sourcing 100% of its electricity from renewable sources, repurchasing a substantial amount of shares, and experiencing growth in key product…

DSM-Firmenich AG has achieved a major sustainability milestone by sourcing 100% of its electricity from renewable sources, while also strengthening its leadership team and making progress on its share repurchase program.

DSM-Firmenich AG has increased its share repurchase program to €1.08 billion, positioning the company for long-term success as it leverages its expertise in sustainable solutions and nutrition to capitalize on growing markets.

DSM-Firmenich AG is making progress on its share repurchase program, driven by the company’s goal to optimize its capital structure and capitalize on the rapidly growing global industrial enzyme market.